1. U.S. Food and Drug Administration. Statement from the FDA Commissioner Scott Gottlieb MD on efforts to safeguard women's health from deceptive health claims and significant risks related to devices marketed for use in medical procedures for “vaginal rejuvenation”. July2018.https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm615130.htm. Accessed August 10 2018.
2. Center for Devices and Radiological. 510(k) Clearances. Device Approvals and Clearances.https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/510kClearances/ucm089319.htm. Accessed December 31 2018.
3. Emerging Trends in Nonsurgical Female Genital Rejuvenation
4. Review and clinical experience exploring evidence, clinical efficacy, and safety regarding nonsurgical treatment of feminine rejuvenation
5. U.S. Food and Drug Administration. Manufacturer and User Facility Device Experience.https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/search.CFM. Accessed August 10 2018.